Tudor Investment Corp ET AL decreased its holdings in Planet Labs PBC (NYSE:PL – Free Report) by 46.4% in the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 351,048 shares of the company’s stock after selling 303,719 shares during the period. Tudor Investment Corp ET AL owned approximately 0.11% of Planet Labs PBC worth $4,557,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently made changes to their positions in the business. Barclays PLC lifted its stake in Planet Labs PBC by 758.1% in the third quarter. Barclays PLC now owns 3,727,743 shares of the company’s stock worth $48,386,000 after purchasing an additional 3,293,333 shares during the last quarter. Invesco Ltd. grew its stake in shares of Planet Labs PBC by 265.6% during the third quarter. Invesco Ltd. now owns 3,450,479 shares of the company’s stock valued at $44,787,000 after buying an additional 2,506,595 shares during the last quarter. Two Sigma Investments LP grew its stake in shares of Planet Labs PBC by 257.5% during the third quarter. Two Sigma Investments LP now owns 2,362,275 shares of the company’s stock valued at $30,662,000 after buying an additional 1,701,535 shares during the last quarter. Vanguard Group Inc. increased its holdings in shares of Planet Labs PBC by 9.7% in the third quarter. Vanguard Group Inc. now owns 18,551,697 shares of the company’s stock worth $240,801,000 after buying an additional 1,637,880 shares during the period. Finally, Marshall Wace LLP lifted its stake in shares of Planet Labs PBC by 10,305.7% in the 2nd quarter. Marshall Wace LLP now owns 1,509,248 shares of the company’s stock valued at $9,206,000 after acquiring an additional 1,494,744 shares during the last quarter. Institutional investors own 41.71% of the company’s stock.
Planet Labs PBC Stock Performance
Shares of NYSE:PL opened at $35.23 on Thursday. The company has a current ratio of 1.65, a quick ratio of 1.64 and a debt-to-equity ratio of 2.37. The company has a 50-day moving average price of $25.63 and a 200-day moving average price of $18.49. The company has a market cap of $11.05 billion, a price-to-earnings ratio of -45.17 and a beta of 1.95. Planet Labs PBC has a 12 month low of $2.79 and a 12 month high of $37.05.
Insiders Place Their Bets
In other news, Director Vijaya Gadde sold 20,000 shares of Planet Labs PBC stock in a transaction that occurred on Thursday, January 22nd. The stock was sold at an average price of $26.77, for a total value of $535,400.00. Following the sale, the director directly owned 250,169 shares in the company, valued at approximately $6,697,024.13. This trade represents a 7.40% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Kristen Robinson sold 47,835 shares of the business’s stock in a transaction that occurred on Wednesday, January 21st. The shares were sold at an average price of $26.96, for a total value of $1,289,631.60. Following the transaction, the director directly owned 222,897 shares in the company, valued at $6,009,303.12. This trade represents a 17.67% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 292,348 shares of company stock worth $7,323,958. Corporate insiders own 17.53% of the company’s stock.
Wall Street Analysts Forecast Growth
Several equities research analysts recently weighed in on PL shares. Zacks Research upgraded Planet Labs PBC from a “strong sell” rating to a “hold” rating in a report on Friday, February 13th. Wedbush lifted their price target on Planet Labs PBC from $30.00 to $40.00 and gave the stock an “outperform” rating in a research note on Friday, March 20th. Northland Securities set a $28.00 price objective on Planet Labs PBC in a research report on Tuesday, January 13th. Deutsche Bank Aktiengesellschaft increased their price objective on Planet Labs PBC from $16.00 to $17.00 and gave the company a “buy” rating in a research note on Thursday, December 11th. Finally, Craig Hallum restated a “buy” rating and issued a $30.00 target price on shares of Planet Labs PBC in a report on Tuesday, January 13th. Six investment analysts have rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Planet Labs PBC presently has an average rating of “Hold” and an average price target of $27.25.
Check Out Our Latest Research Report on PL
Trending Headlines about Planet Labs PBC
Here are the key news stories impacting Planet Labs PBC this week:
- Positive Sentiment: Planet is hiring to operationalize a new Berlin satellite manufacturing facility, marking a concrete step in its European expansion and capacity buildout that should support growth and supply reliability. Planet Labs PBC Accelerates European Expansion
- Positive Sentiment: Company commentary and press coverage highlight strong recent results: record quarterly revenue, a sizeable backlog and the first full-year adjusted EBITDA profitability — indicators of improving unit economics and higher revenue visibility. You’re Up 150% On Planet Labs, What To Do Now?
- Positive Sentiment: Broader space-sector momentum (and speculation around a potential SpaceX IPO) is drawing investor interest to space stocks like Planet Labs, boosting sentiment and fund flows into the group. Is 2026 the Year of Space Stocks?
- Positive Sentiment: Media coverage points out Planet’s strong YTD performance and leadership within industrials, underscoring momentum that can attract momentum-driven and institutional buyers. Planet Labs (PL) Stock Leads Industrial Sector
- Neutral Sentiment: Morgan Stanley raised its price target from $26 to $35 but kept an “equal weight” rating; the new target sits near the current market price, providing validation for recent gains but offering limited near-term upside from this particular call. Morgan Stanley Raises Planet Labs Target to $35
Planet Labs PBC Profile
Planet Labs PBC is a public benefit corporation that operates one of the largest fleets of Earth-imaging satellites, providing high-frequency, high-resolution imagery and data analytics to a broad range of industries. The company’s multi-spectral satellite constellation captures daily snapshots of the planet, enabling clients to monitor changes in agriculture, forestry, urban development, energy infrastructure and environmental conditions. Planet’s imagery platform is designed to support timely decision-making by transforming raw satellite data into actionable insights for business and government users.
Founded in 2010 by former NASA scientists Will Marshall, Robbie Schingler and Chris Boshuizen, Planet Labs grew from a small startup into a key provider in the satellite imaging sector.
Featured Stories
Want to see what other hedge funds are holding PL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Planet Labs PBC (NYSE:PL – Free Report).
Receive News & Ratings for Planet Labs PBC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Planet Labs PBC and related companies with MarketBeat.com's FREE daily email newsletter.
